Cover Image
市場調查報告書

美容雷射的全球市場:醫療設備的開發平台評估

Aesthetic Laser - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 358940
出版日期 內容資訊 英文 94 Pages
訂單完成後即時交付
價格
Back to Top
美容雷射的全球市場:醫療設備的開發平台評估 Aesthetic Laser - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年06月01日 內容資訊: 英文 94 Pages
簡介

本報告提供全球美容整形手術用雷射的市場上,主要開發中產品 (醫療設備) 與其臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進行階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 美容雷射概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 臨床實驗中的開發中產品:各企業

  • 美容雷射的企業:各臨床實驗階段的開發中產品
  • 美容雷射:各臨床實驗階段的開發中產品

第5章 美容雷射市場:企業、產品概要

  • Cynosure, Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Erchonia Corporation
  • Eternity Healthcare Inc.
  • Medifirst Solutions, Inc.
  • Medixsysteme
  • Philips Healthcare
  • PS Advanced Engineering
  • Sybaritic, Inc.

第6章 美容雷射市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Aesthetic Laser - Medical Devices Pipeline Assessment, 2017" provides an overview of Aesthetic Laser currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Aesthetic Laser pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Aesthetic Laser under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Aesthetic Laser and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Aesthetic Laser under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Aesthetic Laser Overview 6

3 Products under Development 7

  • 3.1 Aesthetic Laser - Pipeline Products by Stage of Development 7
  • 3.2 Aesthetic Laser - Pipeline Products by Territory 8
  • 3.3 Aesthetic Laser - Pipeline Products by Regulatory Path 9
  • 3.4 Aesthetic Laser - Pipeline Products by Estimated Approval Date 10
  • 3.5 Aesthetic Laser - Ongoing Clinical Trials 11

4 Aesthetic Laser - Pipeline Products under Development by Companies 12

  • 4.1 Aesthetic Laser Companies - Pipeline Products by Stage of Development 12
  • 4.2 Aesthetic Laser - Pipeline Products by Stage of Development 13

5 Aesthetic Laser Companies and Product Overview 14

  • 5.1 Cutera Inc Company Overview 14
    • 5.1.1 Cutera Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 Erchonia Corp Company Overview 19
    • 5.2.1 Erchonia Corp Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.3 Eternity Healthcare Inc. Company Overview 20
    • 5.3.1 Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.4 Medifirst Solutions Inc Company Overview 21
    • 5.4.1 Medifirst Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.5 Medixsysteme Company Overview 22
    • 5.5.1 Medixsysteme Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.6 PS Advanced Engineering Company Overview 24
    • 5.6.1 PS Advanced Engineering Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.7 Sienna Biopharmaceuticals Inc Company Overview 25
    • 5.7.1 Sienna Biopharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.8 Sybaritic Inc Company Overview 26
    • 5.8.1 Sybaritic Inc Pipeline Products & Ongoing Clinical Trials Overview 26

6 Aesthetic Laser- Recent Developments 27

  • 6.1 May 09, 2017: Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range 27
  • 6.2 May 05, 2017: Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership 27
  • 6.3 May 04, 2017: Olympus Extends Portfolio of EndoTherapy Solutions at DDW 28
  • 6.4 May 01, 2017: Cutera Reports First Quarter 2017 Financial Performance 29
  • 6.5 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 30
  • 6.6 Apr 20, 2017: Cutera Announces Preliminary Financial Results for First Quarter of 2017 and Planned Management Change 31
  • 6.7 Apr 11, 2017: Low-Level Light Therapy Accelerates Hair Growth in Chemotherapy Patients 32
  • 6.8 Apr 10, 2017: Medifirst Solutions Provides Update on International Sales 33
  • 6.9 Mar 28, 2017: Synergy MedSales Introduces Newly FDA-Approved Forma-TK Lasers 33
  • 6.10 Mar 01, 2017: Syneron Candela Unveils PicoWay at the 2017 American Academy of Dermatology (AAD) Annual Meeting 34
  • 6.11 Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance 34
  • 6.12 Feb 15, 2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million 38
  • 6.13 Feb 13, 2017: Cutera Reports Fourth Quarter and Full-Year 2016 Record Revenue and Financial Results 39
  • 6.14 Feb 07, 2017: Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year 40
  • 6.15 Jan 31, 2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer 42
  • 6.16 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 43
  • 6.17 Jan 17, 2017: Medifirst Solutions to Present Its Time Machine Laser in Morocco and Dubai 44
  • 6.18 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 44
  • 6.19 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 45
  • 6.20 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 45
  • 6.21 Jan 09, 2017: Cutera Names James A. Reinstein as its Next President and CEO 46
  • 6.22 Jan 09, 2017: Cutera Announces Record Revenue and Preliminary Financial Results for Fourth Quarter and Full Year 2016 47
  • 6.23 Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors 47
  • 6.24 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 48
  • 6.25 Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology 48
  • 6.26 Dec 06, 2016: CUTERA Launches New PICO Genesis Treatment With enlighten 49
  • 6.27 Nov 29, 2016: Cynosure Receives CFDA Clearance to Market the Icon Aesthetic System in China 50
  • 6.28 Nov 22, 2016: Medifirst Solutions Appoints Bill White to Its Advisory Board 50
  • 6.29 Nov 22, 2016: Medifirst Solutions appoints new advisory board member 51
  • 6.30 Nov 21, 2016: Medifirst Solutions Announces Update on International Sales 51
  • 6.31 Nov 17, 2016: Former Valeant Executive And Former Philidor Ceo Charged In Manhattan Federal Court For Illegal Fraud And Kickback Scheme 52
  • 6.32 Nov 15, 2016: Cynosure Health Welcomes Three New Board Members 53
  • 6.33 Nov 15, 2016: Quanta Aesthetic Lasers names CEO 54
  • 6.34 Nov 09, 2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million 54
  • 6.35 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results 56
  • 6.36 Nov 07, 2016: Cutera Reports Record Third Quarter 2016 Results 59
  • 6.37 Nov 03, 2016: Medifirst Solutions Announces Update Regarding International Sales and Operations 60
  • 6.38 Nov 03, 2016: Cutera Elects J. Daniel Plants as Chairman of the Board 60
  • 6.39 Nov 01, 2016: Cynosure Promotes Doug Delaney to Chief Commercial Officer 61
  • 6.40 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 61
  • 6.41 Oct 25, 2016: Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million 62
  • 6.42 Oct 17, 2016: Medifirst Solutions Announces Update Regarding Sales and Operations 63
  • 6.43 Oct 17, 2016: Syneron Medical Strengthens Senior Management Team 64
  • 6.44 Oct 17, 2016: Syneron Medical Announces Preliminary Third Quarter 2016 Revenue 65
  • 6.45 Oct 13, 2016: Aerolase Hires Prominent Laser Sales Executive as VP Sales to Accelerate Expansion 65
  • 6.46 Oct 11, 2016: Cutera Announces Preliminary Record Third Quarter 2016 Revenue 66
  • 6.47 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer 66
  • 6.48 Sep 13, 2016: Medifirst Solutions Announces Shareholder Update 67
  • 6.49 Sep 13, 2016: Cynosure to Name Stephen J. Webber as New Chief Financial Officer 67
  • 6.50 Aug 30, 2016: Apira Science's iGrow Becomes First Wearable Laser Device to be Cleared by ANVISA in Brazil 68
  • 6.51 Aug 30, 2016: Brazil Approves Apira's iGrow Wearable Laser Device 69
  • 6.52 Aug 25, 2016: Medifirst Solutions Announces Engagement of International Monetary 69
  • 6.53 Aug 22, 2016: Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer 70
  • 6.54 Aug 18, 2016: Cutera Announces Management Changes 71
  • 6.55 Aug 10, 2016: Valeant Pharmaceuticals Comments On SDNY Investigation 71
  • 6.56 Aug 09, 2016: Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results 72
  • 6.57 Aug 08, 2016: Valeant Pharmaceuticals Announces Changes To Executive Management Team 73
  • 6.58 Aug 04, 2016: Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09 75
  • 6.59 Aug 01, 2016: Cutera Reports Second Quarter 2016 Results 77
  • 6.60 Jul 28, 2016: Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors 78
  • 6.61 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 78
  • 6.62 Jul 26, 2016: Cynosure Receives Approval to Market SculpSure in South Korea 79
  • 6.63 Jul 26, 2016: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016 80
  • 6.64 Jul 26, 2016: Medifirst Solutions to Update Shareholders on Corporate and Sales Strategy 81
  • 6.65 Jul 25, 2016: Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Ultra-Short 785nm Wavelength 81
  • 6.66 Jul 18, 2016: Medifirst Solutions Sets Pricing for Its Flagship Product 82
  • 6.67 Jul 15, 2016: Medifirst Solutions Is Granted 510(k) FDA Clearance 83
  • 6.68 Jul 13, 2016: Cynosure Receives Health Canada Authorization to Market SculpSure 83
  • 6.69 Jul 05, 2016: Nail Fungus Sufferers Find Relief in New Laser Treatment 84
  • 6.70 Jun 29, 2016: Medifirst Solutions Updates Shareholders on its FDA 510(K) Submission 84
  • 6.71 Jun 23, 2016: Medifirst Solutions 510(k) Submission Has Been Accepted By The FDA 85
  • 6.72 Jun 17, 2016: Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations 85
  • 6.73 Jun 16, 2016: Medifirst Solutions Announces Successful Completion of Testing for the Time Machine Laser Series 86
  • 6.74 Jun 15, 2016: Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director 86
  • 6.75 Jun 07, 2016: Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results 87
  • 6.76 May 26, 2016: Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller 88
  • 6.77 May 25, 2016: Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer 89
  • 6.78 May 24, 2016: Cynosure Receives FDA Clearance to Market New PicoSure Energy Delivery System for Tattoos and Pigmented Lesions 90

7 Appendix 91

  • 7.1 Methodology 91
  • 7.2 About GlobalData 94
  • 7.3 Contact Us 94
  • 7.4 Disclaimer 94

List of Tables

1.1 List of Tables

  • Table 1: Aesthetic Laser - Pipeline Products by Stage of Development 7
  • Table 2: Aesthetic Laser - Pipeline Products by Territory 8
  • Table 3: Aesthetic Laser - Pipeline Products by Regulatory Path 9
  • Table 4: Aesthetic Laser - Pipeline Pro

List of Figures

1.2 List of Figures

  • Figure 1: Aesthetic Laser - Pipeline Products by Stage of Development 7
  • Figure 2: Aesthetic Laser - Pipeline Products by Territory 8
  • Figure 3: Aesthetic Laser - Pipeline Products by Regulatory Path 9
  • Figure 4: Aesthetic Laser - Pipeline Products by Estimated Approval Date 10
  • Figure 5: Aesthetic Laser - Ongoing Clinical Trials 11
Back to Top